Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$14.4M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$13.9M |
| 3 |
Pilgrim's Pride
PPC
|
+$12.6M |
| 4 |
WW
WW International
WW
|
+$12.1M |
| 5 |
URS
URS CORP
URS
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$26.5M |
| 2 |
GameStop
GME
|
+$16.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.1M |
| 4 |
Jabil
JBL
|
+$11.5M |
| 5 |
SGI
Somnigroup International
SGI
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.74% |
| 2 | Technology | 18.13% |
| 3 | Consumer Discretionary | 17.87% |
| 4 | Healthcare | 10.98% |
| 5 | Consumer Staples | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Nu Skin
NUS
$231M
| $1.89M | 0.06% |
19,755
-36,944
| -65% | -$3.14M |
|
452
Forrester Research
FORR
$224M
| $1.89M | 0.06% |
51,405
+6,969
| +16% | +$247K |
|
|
HMA
453
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $1.88M | 0.06% |
147,073
-32,742
| -18% | -$455K |
|
454
Rogers Corp
ROG
$2.26B
| $1.88M | 0.06% |
31,560
-4,854
| -13% | -$266K |
|
455
Pfizer
PFE
$160B
| $1.87M | 0.06% |
68,563
+49,494
| +260% | +$1.35M |
|
|
OWW
456
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $1.87M | 0.06% |
193,786
+22,010
| +13% | +$217K |
|
457
Liquidity Services
LQDT
$1.36B
| $1.86M | 0.06% |
55,448
-23,089
| -29% | -$734K |
|
458
Brinker International
EAT
$10.6B
| $1.85M | 0.06% |
+45,707
| New | +$1.87M |
|
|
CCC
459
DELISTED
Calgon Carbon Corp
CCC
| $1.85M | 0.06% |
97,520
+29,598
| +44% | +$530K |
|
|
SWFT
460
DELISTED
Swift Transportation Company
SWFT
| $1.85M | 0.06% |
91,443
-152,712
| -63% | -$2.78M |
|
|
BCR
461
DELISTED
CR Bard Inc.
BCR
| $1.83M | 0.06% |
15,933
-14,526
| -48% | -$1.67M |
|
|
PRMW
462
DELISTED
Primo Water Corporation
PRMW
| $1.83M | 0.06% |
238,465
-103,783
| -30% | -$847K |
|
|
PTRY
463
DELISTED
PANTRY INC (THE)
PTRY
| $1.83M | 0.06% |
165,035
-411
| -0.2% | -$4.92K |
|
|
MOLX
464
DELISTED
MOLEX INC
MOLX
| $1.81M | 0.06% |
47,058
-77,955
| -62% | -$2.5M |
|
|
NXGN
465
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.8M | 0.06% |
82,803
-55,602
| -40% | -$1.19M |
|
|
MENT
466
DELISTED
Mentor Graphics Corp
MENT
| $1.79M | 0.06% |
76,427
-65,210
| -46% | -$1.4M |
|
467
Vishay Intertechnology
VSH
$4.85B
| $1.78M | 0.06% |
138,498
+84,526
| +157% | +$1.15M |
|
468
Wabash National
WNC
$490M
| $1.77M | 0.06% |
+152,190
| New | +$1.64M |
|
|
MWIV
469
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $1.77M | 0.06% |
+11,835
| New | +$1.68M |
|
|
IQNT
470
DELISTED
Inteliquent, Inc.
IQNT
| $1.76M | 0.06% |
+182,596
| New | +$1.45M |
|
|
TIF
471
DELISTED
Tiffany & Co.
TIF
| $1.74M | 0.06% |
22,740
+1,125
| +5% | +$88.6K |
|
|
FOE
472
DELISTED
Ferro Corporation
FOE
| $1.74M | 0.06% |
190,401
-61,301
| -24% | -$457K |
|
473
Steel Dynamics
STLD
$32.8B
| $1.73M | 0.06% |
103,607
-157,370
| -60% | -$2.5M |
|
|
CVG
474
DELISTED
Convergys
CVG
| $1.73M | 0.06% |
+92,093
| New | +$1.73M |
|
475
Cognizant
CTSH
$27.9B
| $1.72M | 0.06% |
41,928
-50,330
| -55% | -$1.87M |
|
Similar funds
Joel Greenblatt's Q3 2013 Portfolio in Review
As of Q3 2013, Joel Greenblatt held 1,022 positions worth $3.08B, up 32% from $2.33B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Joel Greenblatt deployed $539M of net new capital in Q3 2013, opening 183 new positions and adding to 402 existing holdings. Its largest new stake was Pilgrim's Pride: 761,966 shares worth $12.8M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Wells Fargo, an estimated $26.5M trimmed.
- Joel Greenblatt's largest Q3 2013 buy was Pilgrim's Pride: 761,966 shares worth $12.8M.
- Joel Greenblatt added most to Tapestry in Q3 2013, an estimated $14.4M increase.
- Joel Greenblatt's biggest Q3 2013 reduction was Wells Fargo, cutting an estimated $26.5M.
- Joel Greenblatt fully exited SALIX PHARMACEUTICALS LTD DEL in Q3 2013, selling an estimated $8.43M.
- Joel Greenblatt's ten largest holdings make up 7.9% of its $3.08B portfolio in Q3 2013.
- Joel Greenblatt opened 183 new positions and closed 141 in Q3 2013.
- Joel Greenblatt's portfolio value rose 32% quarter-over-quarter to $3.08B.
Based on Gotham Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.